These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27602754)

  • 1. Inhibition of never in mitosis A (NIMA)-related kinase-4 reduces survivin expression and sensitizes cancer cells to TRAIL-induced cell death.
    Park SJ; Jo DS; Jo SY; Shin DW; Shim S; Jo YK; Shin JH; Ha YJ; Jeong SY; Hwang JJ; Kim YS; Suh YA; Chang JW; Kim JC; Cho DH
    Oncotarget; 2016 Oct; 7(40):65957-65967. PubMed ID: 27602754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-methoxy-5-amino-N-hydroxybenzamide sensitizes colon cancer cells to TRAIL-induced apoptosis by regulating death receptor 5 and survivin expression.
    Stolfi C; Caruso R; Franzè E; Rizzo A; Rotondi A; Monteleone I; Fantini MC; Pallone F; Monteleone G
    Mol Cancer Ther; 2011 Oct; 10(10):1969-81. PubMed ID: 21817114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels.
    Lu M; Strohecker A; Chen F; Kwan T; Bosman J; Jordan VC; Cryns VL
    Clin Cancer Res; 2008 May; 14(10):3168-76. PubMed ID: 18483385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIF-2α dictates the susceptibility of pancreatic cancer cells to TRAIL by regulating survivin expression.
    Harashima N; Takenaga K; Akimoto M; Harada M
    Oncotarget; 2017 Jun; 8(26):42887-42900. PubMed ID: 28476028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3.
    Chen KF; Chen HL; Liu CY; Tai WT; Ichikawa K; Chen PJ; Cheng AL
    Biochem Pharmacol; 2012 Mar; 83(6):769-77. PubMed ID: 22230479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclopamine sensitizes TRAIL-resistant gastric cancer cells to TRAIL-induced apoptosis via endoplasmic reticulum stress-mediated increase of death receptor 5 and survivin degradation.
    Na YJ; Lee DH; Kim JL; Kim BR; Park SH; Jo MJ; Jeong S; Kim HJ; Lee SY; Jeong YA; Oh SC
    Int J Biochem Cell Biol; 2017 Aug; 89():147-156. PubMed ID: 28624529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose 5-fluorouracil sensitizes HepG2 cells to TRAIL through TRAIL receptor DR5 and survivin-dependent mechanisms.
    Yang L; Wang Y; Zheng H; Zhang D; Wu X; Sun G; Yang T
    J Chemother; 2017 Jun; 29(3):179-188. PubMed ID: 28067150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aurora B confers cancer cell resistance to TRAIL-induced apoptosis via phosphorylation of survivin.
    Yoon MJ; Park SS; Kang YJ; Kim IY; Lee JA; Lee JS; Kim EG; Lee CW; Choi KS
    Carcinogenesis; 2012 Mar; 33(3):492-500. PubMed ID: 22159225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiourea compound AW00178 sensitizes human H1299 lung carcinoma cells to TRAIL-mediated apoptosis.
    Ryu BJ; Hwang MK; Park M; Lee K; Kim SH
    Bioorg Med Chem Lett; 2012 Jun; 22(12):3862-5. PubMed ID: 22622069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibiting survivin expression enhances TRAIL-induced tumoricidal activity in human hepatocellular carcinoma via cell cycle arrest.
    He SQ; Rehman H; Gong MG; Zhao YZ; Huang ZY; Li CH; Zhang WG; Chen XP
    Cancer Biol Ther; 2007 Aug; 6(8):1247-57. PubMed ID: 17700059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NEK4 kinase regulates EMT to promote lung cancer metastasis.
    Ding NH; Zhang L; Xiao Z; Rong ZX; Li Z; He J; Chen L; Ou DM; Liao WH; Sun LQ
    J Cell Mol Med; 2018 Dec; 22(12):5877-5887. PubMed ID: 30247800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wogonin enhances antitumor activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo through ROS-mediated downregulation of cFLIPL and IAP proteins.
    Yang L; Wang Q; Li D; Zhou Y; Zheng X; Sun H; Yan J; Zhang L; Lin Y; Wang X
    Apoptosis; 2013 May; 18(5):618-26. PubMed ID: 23371323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance and susceptibility of human uveal melanoma cells to TRAIL-induced apoptosis.
    Li H; Niederkorn JY; Neelam S; Alizadeh H
    Arch Ophthalmol; 2005 May; 123(5):654-61. PubMed ID: 15883285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linarin sensitizes tumor necrosis factor-related apoptosis (TRAIL)-induced ligand-triggered apoptosis in human glioma cells and in xenograft nude mice.
    Xu ZF; Sun XK; Lan Y; Han C; Zhang YD; Chen G
    Biomed Pharmacother; 2017 Nov; 95():1607-1618. PubMed ID: 28950661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-494 Sensitizes Gastric Cancer Cells to TRAIL Treatment Through Downregulation of Survivin.
    Xu S; Li D; Li T; Qiao L; Li K; Guo L; Liu Y
    Cell Physiol Biochem; 2018; 51(5):2212-2223. PubMed ID: 30537730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL.
    Hari Y; Harashima N; Tajima Y; Harada M
    Oncotarget; 2015 Dec; 6(39):41902-15. PubMed ID: 26506422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALS2CR7 (CDK15) attenuates TRAIL induced apoptosis by inducing phosphorylation of survivin Thr34.
    Park MH; Kim SY; Kim YJ; Chung YH
    Biochem Biophys Res Commun; 2014 Jul; 450(1):129-34. PubMed ID: 24866247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digitoxin sensitizes glioma cells to TRAIL-mediated apoptosis by upregulation of death receptor 5 and downregulation of survivin.
    Lee DH; Lee CS; Kim DW; Ae JE; Lee TH
    Anticancer Drugs; 2014 Jan; 25(1):44-52. PubMed ID: 24045365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of AAV-TRAIL with miR-221-Zip Therapeutic Strategy Overcomes the Resistance to TRAIL Induced Apoptosis in Liver Cancer.
    Ma S; Sun J; Guo Y; Zhang P; Liu Y; Zheng D; Shi J
    Theranostics; 2017; 7(13):3228-3242. PubMed ID: 28900506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination Nanopreparations of a Novel Proapoptotic Drug - NCL-240, TRAIL and siRNA.
    Riehle R; Pattni B; Jhaveri A; Kulkarni A; Thakur G; Degterev A; Torchilin V
    Pharm Res; 2016 Jul; 33(7):1587-601. PubMed ID: 26951567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.